Загрузка...
Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
PURPOSE: To evaluate the efficacy of cytokine-induced killer (CIK) cell therapy in the treatment of hepatocellular carcinoma. MATERIALS AND METHODS: Randomized phase II and III trials on CIK cell-based therapy were identified by electronic searches using a combination of "hepatocellular carcino...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3514101/ https://ncbi.nlm.nih.gov/pubmed/23210562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2162-3619-1-11 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|